Read more

November 13, 2021
3 min read
Save

‘Feasible’ doctor-led strategy improved blood pressure control in rural China

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Village doctors in rural China with basic medical training successfully treated patients with hypertension using a standard protocol and health coaching, serving as a potential model for other low-resource settings.

The VILLAGE BP cluster trial was conducted in 326 villages across rural China. More than half of participants with hypertension living in intervention villages achieved a BP treatment goal of 130/80 mm Hg at 18 months — a more stringent goal than in the Chinese hypertension guidelines — compared with 20% of residents with hypertension who received usual care.

Doctor heartbeat and world
Source: Adobe Stock
Jiang He

“Village doctors — formerly known as barefoot doctors — have traditionally provided basic primary health care in rural China,” Jiang He, MD, PhD, professor and the Joseph S. Copes Chair of Epidemiology in the School of Public Health and Tropical Medicine at Tulane University and director of the Tulane University Translational Science Institute, said during a press conference at the American Heart Association Scientific Sessions. “With appropriate training, they could play an important role in hypertension control in rural China.”

Rising hypertension prevalence in China

The prevalence of hypertension is high and increasing in China, He said. The most recent national survey in 2014 showed 27.8% — 292 million Chinese adults — had hypertension, defined as a BP of at least 140/90 mm Hg. Only 5.5% of rural Chinese adults with hypertension had controlled BP.

For the new trial, He and colleagues randomly assigned 163 villages to a village doctor-led intervention (n = 17,407) and 163 villages to usual care (n = 16,588), with all residents enrolled in the China New Rural Cooperative Medical Scheme. All participants had uncontrolled hypertension, defined as untreated BP of at least 140/90 mm Hg, treated BP of at least 130/80 mm Hg or a BP of at least 130/80 for those with clinical CVD. The mean age of participants was 63 years and mean duration of hypertension was 7 years.

In the intervention group, village doctors were trained to perform standardized BP measurement and implement protocol-based antihypertensive treatment and health coaching, with monthly follow-up. Primary care physicians at township hospitals and hypertension specialists at city or county hospitals supervised the village doctors; all patients in the intervention villages received discounted or free antihypertensive drugs, home BP monitors and health coaching.

At 18 months, 57% of participants living in intervention villages achieved the primary outcome of BP of 130/80 mm Hg or lower compared with 20% of those living in control villages, with a group difference of 37% (P < .001).

From baseline to 18 months, mean systolic and diastolic BP decreased by –26 mm Hg and –15 mm Hg, respectively, in the intervention villages and by –12 mm Hg and –8 mm Hg, respectively, in control villages, with a net difference of –15 mm Hg for systolic BP and –7 mm Hg for diastolic BP (P < .001).

“Our study demonstrated the village doctor-led multifaceted intervention significantly improved blood pressure control among rural residents in China,” He told Healio. “This feasible, effective and sustainable implementation strategy could be scaled up in rural China and other low-resource settings for hypertension control. These findings have important public health significance. Improving BP control in low- and middle-income countries would significantly reduce global burden of CVD.”

‘Opportunity for global health’

These findings marked another important study conducted in rural China that demonstrates an opportunity to improve global health, Manesh Patel, MD, chief of the division of cardiology at Duke University School of Medicine and program committee chair of the 2021 AHA Scientific Sessions, said during the press conference.

“This is a village doctor-led intervention in a low-resource setting, but with the support of primary care physicians, access to medications and BP monitors, and showed us a 15 mm BP reduction, which is certainly going to reduce the mortality of that population,” Patel said. “This is an important message for [cardiologists] not just in how they did it, but also thinking about how we translate that to other parts of the world, including parts of the United States, where we have low-resource settings and certainly a lot of people with hypertension.”